125
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Fragile X molecular investigation and genetic counseling of intellectual disability/developmental delay patients in an Indian scenario

, &
Pages 641-649 | Received 01 Mar 2019, Accepted 20 May 2019, Published online: 04 Jun 2019

References

  • Lamonica DAC, Ferraz PMDP, Ferreira AT, et al. Fragile X syndrome with Dandy-Walker variant: a clinical study of oral and written communicative manifestations. J Soc Bras Fonoaudiol. 2011;23:177–182.
  • Coffee B, Keith K, Albizua I, et al. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet. 2009;85(4):503–514.
  • Hagerman RJ, Hagerman PJ. Testing for fragile X gene mutations throughout the life span. Jama. 2008;300:2419–2421.
  • Wang LW, Berry-Kravis E, Hagerman RJ. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics. 2010;7:264–274.
  • Fu YH, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67:1047–1058.
  • Bassell GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron. 2008;60:201–214.
  • Brown WT. The molecular biology of the fragile X mutation, in Fragile X syndrome: diagnosis, treatment and research 3rdEdn. Hagerman RJ, Hagerman PJ (eds). Baltimore, MD: Johns Hopkins University Press. 2002. 110–135.
  • Pasciuto E, Bagni C. FMRP mRNA targets and diseases. Cell. 2014;158(6):1446–1446.e1.
  • Nolin SL, Sah S, Glicksman A, et al. Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet. 2013;161A(4):771–778.
  • Richards BW, Sylvester PE, Brooker C. Fragile X-linked mental retardation: the martin bell syndrome. J Ment Defic Res. 1981;25:253–256.
  • Lachiewicz AM, Dawson VV, Spiridigliozzi UA. Physical characteristics of young boys with fragile X syndrome: reasons for difficulties in making a diagnosis in young males. Am J Med Genet. 2000;92:229–236.
  • Tassone F. Advanced technologies for the molecular diagnosis of fragile X syndrome. Expert Rev Mol Diagn. 2015;15(11):1465–1473.
  • Bagni C, Tassone F, Neri G, et al. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest. 2012;122(12):4314–4322.
  • Heba AHO, Tarek MK, Heba SAA, et al. Molecular characterization of X chromosome fragility in idiopathic mental retardation. Egyptian J Med Hum Genet. 2016;17(2):165–172.
  • Bastaki LA, Hegazy F, Al-Heneidi MM, et al. Fragile X syndrome: a clinico-genetic study of mentally retarded patients in Kuwait. East Mediterr Health J. 2004;10(1–2):116–124.
  • Iqbal MA, Sakati N, Nester M, et al. Cytogenetic diagnosis of fragile X syndrome: study of 305 suspected cases in Saudi Arabia. Ann Saudi Med. 2000;20(3–4):214–217.
  • Murthy SK, Kar B. Fragile X in mentally retarded population in western India. Am J Hum Genet. 1991;42(49):270.
  • Jain U, Verma IC, Kapoor AK. Prevalence of fragile X(A) syndrome in mentally retarded children at a genetics referral centre in Delhi, India. Indian J Med Res. 1998;108:12–16.
  • Sharma D, Gupta M, Thelma BK. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes. Genet Epidemiol. 2001;20:129–144.
  • Baskaran S, Naseerullah MK, Manjunatha KR, et al. Triplet repeat polymorphism & fragile X syndrome in the Indian context. Indian J Med Res. 1998;107:29–36.
  • Saha S, Karmakar P, Chatterjee C, et al. Fragile X syndrome in Calcutta, India. Ann Clin Biochem. 2001;38:264–271.
  • Pandey UB, Phadke S, Mittal B. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation. Genet Test. 2002;6:335–339.
  • Roy CM, Kabra M, Sharma D, et al. Fragile X screening for FRAXA and FRAXE mutations using PCR based studies: results of a five year study. Indian J Hum Genet. 2006;12:17–22.
  • Curtis-Cioffi KMC, Rodrigueiro DA, Rodrigues VC, et al. Comparison between the polymerase chain reaction-based screening and the Southern blot methods for identification of fragile X syndrome. Genet Test Mol Biomarkers. 2012;16(11):1303–1308.
  • Nahhas FA, Monroe T, Prior J, et al. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory. Genet Test Mol Biomarkers. 2012;16(3):187–192.
  • Strom CM, Huang D, Hantash LY, et al. Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for Fragile X syndrome. Genet Med. 2007;9(4):199–207.
  • Lyon E, Laver T, Jama YP, et al. A simple, high-throughput assay for Fragile X expanded alleles using triple repeat primed PCR and capillary electrophoresis. J Mol Diagn. 2010;12(4):505–511.
  • Hantash FM, Goos DG, Tsao D, et al. Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: implications for fragile X syndrome carrier and newborn screening. Genet Med. 2010;12(3):162–173.
  • Chen L, Hadd A, Sah S, et al. An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. J Mol Diagn. 2010;12(5):589–600.
  • Filipovic-Sadic S, Sah S, Krosting CL, et al. A novel FMR1 PCR Method for the routine detection of low-abundance expanded alleles and full mutations in Fragile X Syndrome. Clin Chem. 2010;56(3):399–408.
  • Poncz M, Solowiejczyk D, Harpel B, et al. Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. Hemoglobin. 1982;6:27–36.
  • Srinivasan M, Dean DD, Agarwal S. Molecular screening of intellectually disabled and premature ovarian failure cases for CGG repeat expansion at FMR1 locus: implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis. Neurol India. 2015;64(6):1175–1179.
  • Heulens I, Suttie M, Postnov A, et al. Craniofacial characteristics of fragile X syndrome in mouse and man. Eur J Hum Genet. 2013;21(8):816–823.
  • Loesch DZ, Huggins R, Petrovic V, et al. Expansion of the CGG repeat in fragile X in the FMR1 gene depends on the sex of the offspring. Am J Hum Genet. 1995;57(6):1408–1413.
  • Tejada MI, Glover G, Martínez F, et al. Molecular testing for fragile X: analysis of 5062 tests from 1105 fragile X families–performed in 12 clinical laboratories in Spain. Biomed Res Int. 2014;195793. DOI:10.1155/2014/195793.
  • Yrigollen CM, Durbin-Johnson B, Gane L, et al. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med. 2012;14(8):729–736.
  • Nolin SL, Glicksman A, Ersalesi N, et al. Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers. Genet Med. 2015;17(5):358–364.
  • Martyn M, Anderson V, Carter AA, et al. Offering fragile X syndrome carrier screening: a prospective mixed-methods observational study comparing carrier screening of pregnant and non-pregnant women in the general population. BMJ Open. 2013;3(9):e003660.
  • Hersh JH, Saul RA; Committee on Genetics. Health supervision for children with fragile X syndrome. Pediatrics. 2011;27(5):994–1006.
  • Hunter J, Rivero-Arias O, Angelov A, et al. Epidemiology of fragile X syndrome: a systematic review and meta-analysis. Am J Med Genet A. 2014;164A(7):1648–1658.
  • Saldarriaga W, Tassone F, González-Teshima LY, et al. Fragile X syndrome. Colomb Med (Cali). 2014;45(4):190–198.
  • Ayoglu FN, Cabuk F, Kiran S, et al. The prevalence of mental retardation by gender, age of diagnosis and location in Zonguldak province, Turkey. Neurosciences (Riyadh). 2008;13(1):57–60.
  • Gallagher A, Hallahan B. Fragile X-associated disorders: a clinical overview. J Neurol. 2012;259(3):401–413.
  • Talisa VB, Boyle L, Crafa D, et al. Autism and anxiety in males with fragile X syndrome: an exploratory analysis of neurobehavioral profiles from a parent survey. Am J Med Genet A. 2014;164A(5):1198–1203.
  • Berry-Kravis E, Raspa M, Hester L, et al. Seizures in fragile X syndrome: characteristics and comorbid diagnoses. Am J Intellect Dev Disabil. 2010;115(6):461–472.
  • Schaefer GB, Mendelsohn NJ. Professional Practice and Guidelines Committee Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399–407.
  • Hall SS, Lightbody AA, Hirt M, et al. Autism in fragile X syndrome: a category mistake? J Am Acad Child Adolesc Psychiatry. 2010;49(9):921–933.
  • Walter EK, Sharon AK, Howard FA, et al. Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment. Pediatrics. 2017;139(S3):S194–S206.
  • Crawford DC, Meadows KL, Newman JL, et al. Prevalence of the fragile X syndrome in African-Americans. Am J Med Genet. 2002;110(3):226–233.
  • Alanay Y, Unal F, Turanli G, et al. A multidisciplinary approach to the management of individuals with fragile X syndrome. J Intellect Disabil Res. 2007;51(2):151–161.
  • Garber KB, Visootsak J, Warren ST. Fragile X syndrome. Eur J Hum Genet. 2008;16(6):666–672.
  • Muthuswamy S, Dean DD, Agarwal S. A pilot study on assessment of triplet repeat primed PCR for fragile X syndrome diagnosis. In: Avadhanam S, Jyothsna G, Kashyap A, editors. Next generation DNA led technologies. Springer briefs in applied sciences and technology. Singapore: Springer; 2016;91-96.
  • Bailey DB Jr., Raspa M, Bishop E, et al. Health and economic consequences of fragile X syndrome for caregivers. J Dev Behav Pediatr. 2012;33(9):705–712.
  • Bailey DB, Raspa M, Holiday D, et al. Functional skills of individuals with fragile x syndrome: a lifespan cross-sectional analysis. Am J Intellect Dev Disabil. 2009;114(4):289–303.
  • Sacco P, Capkun-Niggli G, Zhang X, et al. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013;6(2):73–83.
  • Yim SY, Bo HJ, Yang JA, et al. Fragile X syndrome in Korea: a case series and a review of the literature. J Korean Med Sci. 2008;23(3):470–476.
  • Bailey D Jr, Raspa B, Bishop E, et al. No change in the age of diagnosis for fragile X syndrome: findings from a national parent survey. Pediatrics. 2009;124(2):527–533.
  • Cotter M, Archibald AD, Mcclaren BJ, et al. Clinical audit of genetic testing and referral patterns for fragile X and associated conditions. Am J Med Genet A. 2016;170(6):1439–1449.
  • Ouyang L, Grosse SD, Riley C, et al. A comparison of family financial and employment impacts of fragile X syndrome, autism spectrum disorders, and intellectual disability. J Res Dev Disabil. 2014;35(7):1518–1527.
  • Dean DD, Agarwal S, Kapoor D, et al. Molecular characterization of FMR1 gene in reproductive age women and Premature Ovarian Insufficiency cases by TP-PCR. Journal of molecular diagnosis and therapy.2017, 22: 91-100.
  • Vimala D, Rajan AK, Siva R, et al. A study to assess the knowledge, attitude and practices of family members of clients with mental illness. Nurs J India. 2003;94:223–224.
  • Raguram R, Weiss MG, Channabasavanna SM, et al. Stigma, depression, and somatization in South India. Am J Psychiatry. 1996;153:1043–1049.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.